{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:43:31Z","timestamp":1793054611159,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program in Xinjiang Uygur Autonomous Region","award":["2022B03019-4"],"award-info":[{"award-number":["2022B03019-4"]}]},{"name":"Natural Science Foundation of the Xinjiang Uygur Autonomous Region Science and Technology Department","award":["2022D01C511"],"award-info":[{"award-number":["2022D01C511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48786-8","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:18:17Z","timestamp":1776395897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pan-cancer characterization of POSTN and its clinical and microenvironmental associations in ER+ breast cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Xiaoyi","family":"Zhai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buerlan","family":"Yeerkenbieke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilinaer","family":"Yeerxiati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"48786_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-023-01876-x","volume":"22","author":"C Ma","year":"2023","unstructured":"Ma, C. et al. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol. Cancer. 22, 170. https:\/\/doi.org\/10.1186\/s12943-023-01876-x (2023).","journal-title":"Mol. Cancer"},{"key":"48786_CR2","doi-asserted-by":"publisher","first-page":"1240098","DOI":"10.3389\/fonc.2023.1240098","volume":"13","author":"A Roheel","year":"2023","unstructured":"Roheel, A. et al. Global epidemiology of breast cancer based on risk factors: a systematic review. Front. Oncol. 13, 1240098. https:\/\/doi.org\/10.3389\/fonc.2023.1240098 (2023).","journal-title":"Front. Oncol."},{"key":"48786_CR3","doi-asserted-by":"publisher","first-page":"1270877","DOI":"10.3389\/fonc.2023.1270877","volume":"13","author":"P Contiero","year":"2023","unstructured":"Contiero, P. et al. Causes of death in women with breast cancer: a risks and rates study on a population-based cohort. Front. Oncol. 13, 1270877. https:\/\/doi.org\/10.3389\/fonc.2023.1270877 (2023).","journal-title":"Front. Oncol."},{"key":"48786_CR4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.20892\/j.issn.2095-3941.2021.0676","volume":"19","author":"R Ding","year":"2022","unstructured":"Ding, R. et al. Breast cancer screening and early diagnosis in Chinese women. Cancer Biol. Med. 19, 450\u2013467. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2021.0676 (2022).","journal-title":"Cancer Biol. Med."},{"key":"48786_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1002\/cbin.11740","volume":"46","author":"C Wang","year":"2022","unstructured":"Wang, C., Cheng, D., Pan, C., Wang, C. & Nie, Z. Research progress of Bub3 gene in malignant tumors. Cell. Biol. Int. 46, 673\u2013682. https:\/\/doi.org\/10.1002\/cbin.11740 (2022).","journal-title":"Cell. Biol. Int."},{"key":"48786_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10555-024-10233-3","volume":"44","author":"Y De Oliveira Macena","year":"2024","unstructured":"De Oliveira Macena, Y. et al. The roles of periostin derived from cancer-associated fibroblasts in tumor progression and treatment response. Cancer Metastasis Rev. 44, 11. https:\/\/doi.org\/10.1007\/s10555-024-10233-3 (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"48786_CR7","doi-asserted-by":"publisher","first-page":"112090","DOI":"10.1016\/j.celrep.2023.112090","volume":"42","author":"T Wei","year":"2023","unstructured":"Wei, T. et al. Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer. Cell. Rep. 42, 112090. https:\/\/doi.org\/10.1016\/j.celrep.2023.112090 (2023).","journal-title":"Cell. Rep."},{"key":"48786_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","volume":"22","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers. Mol. Cancer. 22, 58. https:\/\/doi.org\/10.1186\/s12943-023-01725-x (2023).","journal-title":"Mol. Cancer"},{"key":"48786_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/path.6395","volume":"265","author":"X Lu","year":"2025","unstructured":"Lu, X. et al. Extracellular matrix cancer-associated fibroblasts promote stromal fibrosis and immune exclusion in triple-negative breast cancer. J. Pathol. 265, 385\u2013399. https:\/\/doi.org\/10.1002\/path.6395 (2025).","journal-title":"J. Pathol."},{"key":"48786_CR10","doi-asserted-by":"publisher","first-page":"e71546","DOI":"10.1096\/fj.202504456RR","volume":"40","author":"H Chen","year":"2026","unstructured":"Chen, H., Peng, Y., Ji, Z. & Dong, J. SPP1+ Macrophage-POSTN+ Fibroblast-Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer. FASEB J. 40, e71546. https:\/\/doi.org\/10.1096\/fj.202504456RR (2026).","journal-title":"FASEB J."},{"key":"48786_CR11","doi-asserted-by":"publisher","first-page":"1509342","DOI":"10.3389\/fgene.2024.1509342","volume":"15","author":"G Li","year":"2024","unstructured":"Li, G. et al. BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks. Front. Genet. 15, 1509342. https:\/\/doi.org\/10.3389\/fgene.2024.1509342 (2024).","journal-title":"Front. Genet."},{"key":"48786_CR12","doi-asserted-by":"publisher","first-page":"1134063","DOI":"10.3389\/fonc.2023.1134063","volume":"13","author":"C Sun","year":"2023","unstructured":"Sun, C. et al. Identification and validation of PCSK9 as a prognostic and immune-related influencing factor in tumorigenesis: a pan-cancer analysis. Front. Oncol. 13, 1134063. https:\/\/doi.org\/10.3389\/fonc.2023.1134063 (2023).","journal-title":"Front. Oncol."},{"key":"48786_CR13","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1002\/biof.2142","volume":"51","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy. Biofactors 51, e2142. https:\/\/doi.org\/10.1002\/biof.2142 (2025).","journal-title":"Biofactors"},{"key":"48786_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12935-022-02714-8","volume":"22","author":"S Dorafshan","year":"2022","unstructured":"Dorafshan, S. et al. Periostin: biology and function in cancer. Cancer Cell. Int. 22, 315. https:\/\/doi.org\/10.1186\/s12935-022-02714-8 (2022).","journal-title":"Cancer Cell. Int."},{"key":"48786_CR15","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41746-025-02172-2","volume":"8","author":"Z Gong","year":"2025","unstructured":"Gong, Z. et al. Machine learning identifies TIME subtypes linking EGFR mutations and immune states in lung adenocarcinoma. NPJ Digit. Med. 8, 796. https:\/\/doi.org\/10.1038\/s41746-025-02172-2 (2025).","journal-title":"NPJ Digit. Med."},{"key":"48786_CR16","doi-asserted-by":"publisher","first-page":"796","DOI":"10.21147\/j.issn.1000-9604.2025.05.11","volume":"37","author":"W Xia","year":"2025","unstructured":"Xia, W. et al. Molecular subtypes and prognostic signature rooted in disulfidptosis highlight tumor microenvironment in lung adenocarcinoma. Chin. J. Cancer Res. 37, 796\u2013820. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.05.11 (2025).","journal-title":"Chin. J. Cancer Res."},{"key":"48786_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.21147\/j.issn.1000-9604.2025.06.11","volume":"37","author":"P Zhang","year":"2025","unstructured":"Zhang, P. et al. Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance. Chin. J. Cancer Res. 37, 1000\u20131019. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2025.06.11 (2025).","journal-title":"Chin. J. Cancer Res."},{"key":"48786_CR18","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. iMLGAM: Integrated Machine Learning and Genetic Algorithm-driven Multiomics analysis for pan-cancer immunotherapy response prediction. iMeta 4, e70011. https:\/\/doi.org\/10.1002\/imt2.70011 (2025).","journal-title":"iMeta"},{"key":"48786_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00262-024-03675-9","volume":"73","author":"KX Yu","year":"2024","unstructured":"Yu, K. X., Yuan, W. J., Wang, H. Z. & Li, Y. X. Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion. Cancer Immunol. Immunother. 73, 115. https:\/\/doi.org\/10.1007\/s00262-024-03675-9 (2024).","journal-title":"Cancer Immunol. Immunother"},{"key":"48786_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords, L. et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 42, 396\u2013412e5. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.021 (2024).","journal-title":"Cancer Cell."},{"key":"48786_CR21","doi-asserted-by":"publisher","first-page":"774905","DOI":"10.3389\/fmolb.2021.774905","volume":"8","author":"L Sun","year":"2022","unstructured":"Sun, L. et al. Identification of TRPM2 as a Marker Associated With Prognosis and Immune Infiltration in Kidney Renal Clear Cell Carcinoma. Front. Mol. Biosci. 8, 774905. https:\/\/doi.org\/10.3389\/fmolb.2021.774905 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"48786_CR22","doi-asserted-by":"publisher","first-page":"e010083","DOI":"10.1136\/jitc-2024-010083","volume":"13","author":"T Inthanachai","year":"2025","unstructured":"Inthanachai, T. et al. Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study. J. Immunother Cancer. 13, e010083. https:\/\/doi.org\/10.1136\/jitc-2024-010083 (2025).","journal-title":"J. Immunother Cancer"},{"key":"48786_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/acs.jproteome.3c00545","volume":"23","author":"L M\u00e9ar","year":"2024","unstructured":"M\u00e9ar, L. et al. Transcriptomics and Spatial Proteomics for Discovery and Validation of Missing Proteins in the Human Ovary. J. Proteome Res. 23, 238\u2013248. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00545 (2024).","journal-title":"J. Proteome Res."},{"key":"48786_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11033-024-10207-2","volume":"52","author":"S Heydari","year":"2025","unstructured":"Heydari, S., Peymani, M., Hashemi, M., Ghaedi, K. & Entezari, M. Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers. Mol. Biol. Rep. 52, 151. https:\/\/doi.org\/10.1007\/s11033-024-10207-2 (2025).","journal-title":"Mol. Biol. Rep."},{"key":"48786_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2478\/raon-2025-0014","volume":"59","author":"N Hribernik","year":"2025","unstructured":"Hribernik, N. et al. Early-time-point 18F-FDG-PET\/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy. Radiol. Oncol. 59, 43\u201353. https:\/\/doi.org\/10.2478\/raon-2025-0014 (2025).","journal-title":"Radiol. Oncol."},{"key":"48786_CR26","doi-asserted-by":"publisher","first-page":"1438364","DOI":"10.3389\/fimmu.2024.1438364","volume":"15","author":"Y Zhong","year":"2024","unstructured":"Zhong, Y. et al. Investigating the impact of STING pathway activation on breast cancer treatment outcomes: development and validation of a prognostic model. Front. Immunol. 15, 1438364. https:\/\/doi.org\/10.3389\/fimmu.2024.1438364 (2024).","journal-title":"Front. Immunol."},{"key":"48786_CR27","doi-asserted-by":"publisher","first-page":"8693","DOI":"10.1002\/cam4.4341","volume":"10","author":"Y Jin","year":"2021","unstructured":"Jin, Y. et al. Identification of novel subtypes based on ssGSEA in immune-related prognostic signature for tongue squamous cell carcinoma. Cancer Med. 10, 8693\u20138707. https:\/\/doi.org\/10.1002\/cam4.4341 (2021).","journal-title":"Cancer Med."},{"key":"48786_CR28","doi-asserted-by":"publisher","first-page":"e70063","DOI":"10.1002\/mgg3.70063","volume":"13","author":"YY Zhang","year":"2025","unstructured":"Zhang, Y. Y. et al. Identification and Validation of Biomarkers in Metabolic Dysfunction-Associated Steatohepatitis Using Machine Learning and Bioinformatics. Mol. Genet. Genomic Med. 13, e70063. https:\/\/doi.org\/10.1002\/mgg3.70063 (2025).","journal-title":"Mol. Genet. Genomic Med."},{"key":"48786_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12967-025-06178-y","volume":"23","author":"X Cheng","year":"2025","unstructured":"Cheng, X. et al. Integrative analysis of T cell-mediated tumor killing-related genes reveals KIF11 as a novel therapeutic target in esophageal squamous cell carcinoma. J. Transl Med. 23, 197. https:\/\/doi.org\/10.1186\/s12967-025-06178-y (2025).","journal-title":"J. Transl Med."},{"key":"48786_CR30","doi-asserted-by":"publisher","first-page":"e0316923","DOI":"10.1371\/journal.pone.0316923","volume":"20","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. NOTCH1 promotes the elevation of GM-CSF and IL-6 through the EZH2\/STAT3 pathway to facilitate the fibrotic state of the myocardium in DLBCL. PLoS One. 20, e0316923. https:\/\/doi.org\/10.1371\/journal.pone.0316923 (2025).","journal-title":"PLoS One"},{"key":"48786_CR31","doi-asserted-by":"publisher","first-page":"1387860","DOI":"10.3389\/fonc.2024.1387860","volume":"14","author":"R Ma","year":"2024","unstructured":"Ma, R. et al. Identification of key genes associated with endometriosis and endometrial cancer by bioinformatics analysis. Front. Oncol. 14, 1387860. https:\/\/doi.org\/10.3389\/fonc.2024.1387860 (2024).","journal-title":"Front. Oncol."},{"key":"48786_CR32","doi-asserted-by":"publisher","unstructured":"Liu, J. et al. Single-cell profiling and clinical characteristics analysis of lung squamous carcinoma. Funct. Integr. Genomics. 25 https:\/\/doi.org\/10.1007\/s10142-025-01556-7 (2025).","DOI":"10.1007\/s10142-025-01556-7"},{"key":"48786_CR33","doi-asserted-by":"publisher","unstructured":"Chen, Y. et al. Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis. Cancer Rep (Hoboken) 7, e (1990). https:\/\/doi.org\/10.1002\/cnr2.1990 (2024).","DOI":"10.1002\/cnr2.1990"},{"key":"48786_CR34","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3390\/ijms26041673","volume":"26","author":"FA Abdulrahman","year":"2025","unstructured":"Abdulrahman, F. A. et al. zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment Perspective. Int. J. Mol. Sci. 26, 1673. https:\/\/doi.org\/10.3390\/ijms26041673 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"48786_CR35","doi-asserted-by":"publisher","first-page":"e70584","DOI":"10.1002\/cam4.70584","volume":"14","author":"S Jiang","year":"2025","unstructured":"Jiang, S. et al. Significance of Gelsolin Superfamily Genes in Diagnosis, Prognosis and Immune Microenvironment Regulation for Endometrial Cancer. Cancer Med. 14, e70584. https:\/\/doi.org\/10.1002\/cam4.70584 (2025).","journal-title":"Cancer Med."},{"key":"48786_CR36","doi-asserted-by":"publisher","first-page":"1128244","DOI":"10.3389\/fimmu.2023.1128244","volume":"14","author":"W Zhi","year":"2023","unstructured":"Zhi, W. et al. PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma. Front. Immunol. 14, 1128244. https:\/\/doi.org\/10.3389\/fimmu.2023.1128244 (2023).","journal-title":"Front. Immunol."},{"key":"48786_CR37","doi-asserted-by":"publisher","first-page":"14820","DOI":"10.1038\/s41598-024-65425-2","volume":"14","author":"P Li","year":"2024","unstructured":"Li, P., Cui, P., Yue, Q., Xu, Z. & Liu, Z. Exploring the potential biological significance of KDELR family genes in lung adenocarcinoma. Sci. Rep. 14, 14820. https:\/\/doi.org\/10.1038\/s41598-024-65425-2 (2024).","journal-title":"Sci. Rep."},{"key":"48786_CR38","doi-asserted-by":"publisher","first-page":"D1278","DOI":"10.1093\/nar\/gkae954","volume":"53","author":"J Zeng","year":"2025","unstructured":"Zeng, J. et al. CancerSCEM 2.0: an updated data resource of single-cell expression map across various human cancers. Nucleic Acids Res. 53, D1278\u2013D1286. https:\/\/doi.org\/10.1093\/nar\/gkae954 (2025).","journal-title":"Nucleic Acids Res."},{"key":"48786_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3390\/cancers14030657","volume":"14","author":"LM Mustachio","year":"2022","unstructured":"Mustachio, L. M., Roszik, J., Single-Cell & Sequencing Current Applications in Precision Onco-Genomics and Cancer Therapeutics. Cancers (Basel). 14, 657. https:\/\/doi.org\/10.3390\/cancers14030657 (2022).","journal-title":"Cancers (Basel)"},{"key":"48786_CR40","doi-asserted-by":"publisher","first-page":"26377","DOI":"10.1038\/s41598-024-78341-2","volume":"14","author":"M Zhong","year":"2024","unstructured":"Zhong, M. et al. The role of adjuvant endocrine treatment in ER+, PR-, HER2- early breast cancer: a retrospective study of real-world data. Sci. Rep. 14, 26377. https:\/\/doi.org\/10.1038\/s41598-024-78341-2 (2024).","journal-title":"Sci. Rep."},{"key":"48786_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/pro6.1245","volume":"8","author":"J Qin","year":"2024","unstructured":"Qin, J. et al. [18F]-NOTA-FAPI-04 PET\/CT downgraded the staging of a breast cancer patient and changed their treatment management. Precision radiation Oncol. 8, 227\u2013231. https:\/\/doi.org\/10.1002\/pro6.1245 (2024).","journal-title":"Precision radiation Oncol."},{"key":"48786_CR42","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1158\/0008-5472.CAN-22-2412","volume":"83","author":"JL Null","year":"2023","unstructured":"Null, J. L. et al. Periostin+ Stromal Cells Guide Lymphovascular Invasion by Cancer Cells. Cancer Res. 83, 2105\u20132122. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2412 (2023).","journal-title":"Cancer Res."},{"key":"48786_CR43","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s00109-023-02384-7","volume":"101","author":"F Takatsu","year":"2023","unstructured":"Takatsu, F. et al. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer. J. Mol. Med. (Berl). 101, 1603\u20131614. https:\/\/doi.org\/10.1007\/s00109-023-02384-7 (2023).","journal-title":"J. Mol. Med. (Berl)"},{"key":"48786_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pro6.1221","volume":"8","author":"K Takeda","year":"2024","unstructured":"Takeda, K. et al. Lymphocytopenia following adjuvant radiotherapy for breast cancer. Precision radiation Oncol. 8, 22\u201329. https:\/\/doi.org\/10.1002\/pro6.1221 (2024).","journal-title":"Precision radiation Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48786-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:46:41Z","timestamp":1780962401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48786-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48786"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48786-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Affiliated Cancer Hospital of Xinjiang Medical University (Approval No. K-2024014) in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"17798"}}